Does ZYTIGA Cause Malignant neoplasm progression? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with ZYTIGA. This represents 1.4% of all adverse event reports for ZYTIGA.
6
Reports of Malignant neoplasm progression with ZYTIGA
1.4%
of all ZYTIGA reports
1
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ZYTIGA?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZYTIGA. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ZYTIGA Cause?
Death (73)
Disease progression (31)
Prostatic specific antigen increased (27)
Blood alkaline phosphatase increased (19)
Drug ineffective (19)
Asthenia (17)
Fatigue (17)
Anaemia (15)
Haemoglobin decreased (12)
Pain (12)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ZYTIGA Alternatives Have Lower Malignant neoplasm progression Risk?
ZYTIGA vs ZYVOX
ZYTIGA vs 5-FLUOROURACIL
ZYTIGA vs 5-FU
ZYTIGA vs 6-ACETYLMORPHINE
ZYTIGA vs ABACAVIR